X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs STERLING BIOTECH - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD STERLING BIOTECH STRIDES SHASUN LTD/
STERLING BIOTECH
 
P/E (TTM) x 15.2 -1.9 - View Chart
P/BV x 1.8 0.1 2,343.3% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 STRIDES SHASUN LTD   STERLING BIOTECH
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
STERLING BIOTECH
Dec-13
STRIDES SHASUN LTD/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,27511 12,140.0%   
Low Rs9183 27,000.0%   
Sales per share (Unadj.) Rs389.626.8 1,453.2%  
Earnings per share (Unadj.) Rs28.0-15.0 -187.0%  
Cash flow per share (Unadj.) Rs48.9-5.5 -895.1%  
Dividends per share (Unadj.) Rs4.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs303.154.9 552.3%  
Shares outstanding (eoy) m89.42267.87 33.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.80.3 1,085.5%   
Avg P/E ratio x39.2-0.5 -8,436.1%  
P/CF ratio (eoy) x22.4-1.3 -1,762.3%  
Price / Book Value ratio x3.60.1 2,856.2%  
Dividend payout %16.10-   
Avg Mkt Cap Rs m98,0361,862 5,265.9%   
No. of employees `0005.81.4 428.4%   
Total wages/salary Rs m5,881547 1,075.6%   
Avg. sales/employee Rs Th6,005.95,303.3 113.2%   
Avg. wages/employee Rs Th1,014.0403.8 251.1%   
Avg. net profit/employee Rs Th431.2-2,959.0 -14.6%   
INCOME DATA
Net Sales Rs m34,8347,181 485.1%  
Other income Rs m1,68643 3,957.3%   
Total revenues Rs m36,5207,223 505.6%   
Gross profit Rs m6,428947 678.8%  
Depreciation Rs m1,8722,543 73.6%   
Interest Rs m2,2694,377 51.8%   
Profit before tax Rs m3,973-5,931 -67.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470-1,924 -24.4%   
Profit after tax Rs m2,501-4,007 -62.4%  
Gross profit margin %18.513.2 139.9%  
Effective tax rate %11.832.4 36.5%   
Net profit margin %7.2-55.8 -12.9%  
BALANCE SHEET DATA
Current assets Rs m38,16514,335 266.2%   
Current liabilities Rs m30,40249,809 61.0%   
Net working cap to sales %22.3-494.0 -4.5%  
Current ratio x1.30.3 436.2%  
Inventory Days Days77403 19.2%  
Debtors Days Days104171 61.2%  
Net fixed assets Rs m37,63955,432 67.9%   
Share capital Rs m894268 333.8%   
"Free" reserves Rs m26,21013,935 188.1%   
Net worth Rs m27,10514,701 184.4%   
Long term debt Rs m16,3779,478 172.8%   
Total assets Rs m81,16873,988 109.7%  
Interest coverage x2.8-0.4 -774.9%   
Debt to equity ratio x0.60.6 93.7%  
Sales to assets ratio x0.40.1 442.2%   
Return on assets %5.90.5 1,173.3%  
Return on equity %9.2-27.3 -33.9%  
Return on capital %12.1-6.4 -187.5%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m13,4651,860 724.0%   
Fx outflow Rs m4,07625 16,374.8%   
Net fx Rs m9,3891,835 511.7%   
CASH FLOW
From Operations Rs m2,8811,719 167.6%  
From Investments Rs m-7,051-3,148 224.0%  
From Financial Activity Rs m3,3821,426 237.2%  
Net Cashflow Rs m-788-3 23,163.5%  

Share Holding

Indian Promoters % 27.7 33.9 81.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 0.0 -  
FIIs % 8.6 9.9 86.9%  
ADR/GDR % 0.0 16.9 -  
Free float % 25.9 39.3 65.9%  
Shareholders   56,241 21,482 261.8%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare STRIDES SHASUN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Surges 300 Points; Tata Steel Up 3.5%(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading near all-time high levels. Sectoral indices are trading on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jan 23, 2018 03:34 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 5-YR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS